New York State Common Retirement Fund Athira Pharma, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$2.36 - $3.59 $53,553 - $81,464	-22,692 Reduced 98.86%	262 $1,000
Q3 2022 Nov 08, 2022	BUY	$2.93 - $3.96 $278 - $376	95 Added 0.42%	22,954 $68,000
Q2 2022 Aug 04, 2022	BUY	$2.74 - $13.43 $12,667 - $62,086	4,623 Added 25.35%	22,859 $70,000
Q1 2022 May 05, 2022	BUY	$8.96 - $13.51 $152 - $229	17 Added 0.09%	18,236 $246,000
Q4 2021 Feb 02, 2022	SELL	$9.17 - $16.39 $366 - $655	-40 Reduced 0.22%	18,219 $237,000
Q3 2021 Nov 02, 2021	SELL	$9.15 - $11.09 $86,513 - $104,855	-9,455 Reduced 34.12%	18,259 $171,000
Q2 2021 Aug 02, 2021	BUY	$10.24 - $20.87 $151,695 - $309,168	14,814 Added 114.84%	27,714 $284,000
Q1 2021 May 11, 2021	BUY	$16.9 - $29.77 $57,459 - $101,218	3,400 Added 35.79%	12,900 $237,000
Q4 2020 Feb 08, 2021	BUY	$16.48 - $34.3 $156,560 - $325,850	9,500 New	9,500 $325,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.